Netherlands
Arcturus Therapeutics Holdings Inc (ARCT) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and Strategic Advances
Revenue: $49.9 million for Q2 2024, up from $10.5 million in Q2 2023.Total Operating Expenses: $71 million for Q2 2024, compared to $65.9 million in Q2 2023.Re